SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management-Reference-Cited by-同舟云学术

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

Published:2018-07-20 Issue:8 Volume:41 Page:1543-1556
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

van Baar Michaël J.B.^ORCID,van Ruiten Charlotte C.,Muskiet Marcel H.A.,van Bloemendaal Liselotte,IJzerman Richard G.,van Raalte Daniël H.

Publisher

American Diabetes Association

Subject

Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference99 articles.

1. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018

2. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline (NG28), December 2015. Available from https://www.nice.org.uk/guidance/ng28. Accessed 17 March 2018

3. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 executive summary;Garber;Endocr Pract,2017

4. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

5. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial;Diabetes & Metabolism Journal;2024-09-30

2. Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database;Acta Diabetologica;2024-08-29

3. The relationship between SGLT2 and systemic blood pressure regulation;Hypertension Research;2024-05-23

4. SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea;Scientific Reports;2024-04-29

5. Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment;BMC Nephrology;2024-04-22